03:27 Tue 30 Apr 2019
Adv Medical Soln Grp - Director/PDMR Shareholding
|
|
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR Shareholding
Following these transactions the beneficial ownership of
Director/PDMR |
Date purchased |
Shares purchased |
Resultant holding |
% of issued share capital |
Chief Executive Officer |
|
10,182 |
1,494,577 |
0.7% |
Chief Financial Officer |
|
3,847 |
59,426 |
0.028% |
Mr Meredith subsequently sold 33,007 Ordinary Shares of 5p each on
PDMR |
Holding prior to exercise (including DSB purchase) |
Number of shares exercised |
Dividend Shares received |
Number of shares sold |
Sale price (p) |
Resultant holding |
% of issued share capital |
|
1,494,577 |
32,638 |
369 |
33,007 |
330p |
1,494,577 |
0.7% |
This award is in respect of the part of their bonus that the Directors and PDMRs are compulsorily required to defer for the 2018 financial year. These options vest at the end of three years. Details of the current DAB holdings of the Directors/PDMRs following these awards and the exercise of DAB options by
Director/PDMR |
Options prior to grant/exercise |
Options granted |
Options exercised |
Resultant holding |
Chief Executive Officer |
77,756 |
12,859 |
32,638 |
57,977 |
Chief Financial Officer |
20,333 |
2,209 |
- |
22,542 |
Director/PDMR |
Options prior to grant |
Options granted |
Resultant holding |
Chief Executive Officer |
476,482 |
182,510
|
658,992
|
Chief Financial Officer |
105,739
|
38,783
|
144,522
|
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||
a) |
|
||||
2. |
Reason for the notification |
||||
a) |
Position/status: Director/PDMR |
||||
b) |
Initial notification/Amendment: Initial Notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
|
||||
b) |
LEI: 213800HJP6OWOSZI1L74 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a) |
Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
||||
b) |
Nature of the transactions: · Purchase of 10,182 Ordinary Shares as part of the Deferred Share Bonus Plan on |
||||
c) |
Price(s) and volume(s): Sale of shares:
|
||||
d) |
Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a |
||||
e) |
Date of the transaction: |
||||
f) |
Place of the transaction: |
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||
a) |
|
||||
2. |
Reason for the notification |
||||
a) |
Position/status: Director/PDMR |
||||
b) |
Initial notification/Amendment: Initial Notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
|
||||
b) |
LEI: 213800HJP6OWOSZI1L74 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a) |
Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
||||
b) |
Nature of the transactions: · Purchase of 3,847 Ordinary Shares as part of the Deferred Share Bonus Plan on |
||||
c) |
Price(s) and volume(s): Sale of shares:
|
||||
d) |
Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a |
||||
e) |
Date of the transaction: |
||||
f) |
Place of the transaction: |
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||
a) |
|
||||
2. |
Reason for the notification |
||||
a) |
Position/status: Director/PDMR |
||||
b) |
Initial notification/Amendment: Initial Notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
|
||||
b) |
LEI: 213800HJP6OWOSZI1L74 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a) |
Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
||||
b) |
Nature of the transactions: · Exercise of 32,638 shares from the Deferred Annual Bonus Plan · Award of 369 Dividend Shares from the Deferred Annual Bonus Plan · Sale of 33,007 Ordinary Shares of 5p |
||||
c) |
Price(s) and volume(s): Sale of shares:
|
||||
d) |
Aggregated information: (Relates to those shares sold only) Aggregated volume: 33,007 Aggregated price: £3.300 |
||||
e) |
Date of the transaction: |
||||
f) |
Place of the transaction: |
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||
a) |
|
||||
2. |
Reason for the notification |
||||
a) |
Position/status: Director/PDMR |
||||
b) |
Initial notification/Amendment: Initial Notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
|
||||
b) |
LEI: 213800HJP6OWOSZI1L74 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a) |
Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
||||
b) |
Nature of the transactions: · Grant of 182,510 options under the Advanced Medical Solutions Long Term Incentive Plan on · Grant of 12,859 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on |
||||
c) |
Price(s) and volume(s): Sale of shares:
|
||||
d) |
Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a |
||||
e) |
Date of the transaction: |
||||
f) |
Place of the transaction: |
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||
a) |
|
||||
2. |
Reason for the notification |
||||
a) |
Position/status: Director/PDMR |
||||
b) |
Initial notification/Amendment: Initial Notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
|
||||
b) |
LEI: 213800HJP6OWOSZI1L74 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a) |
Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
||||
b) |
Nature of the transactions: · Grant of 38,783 options under the Advanced Medical Solutions Long Term Incentive Plan on · Grant of 2,209 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on |
||||
c) |
Price(s) and volume(s): Sale of shares:
|
||||
d) |
Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a |
||||
e) |
Date of the transaction: |
||||
f) |
Place of the transaction: |
-End -
For further information, please visit www.admedsol.com or contact:
|
Tel: +44 (0) 1606 545508 |
|
|
|
|
|
Tel: +44 (0) 20 3709 5700 |
|
|
|
|
|
Tel: +44 (0) 20 7597 5970 |
|
|
About
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include tissue adhesives, sutures, biosurgical devices, internal sealants, silver alginates, alginates and foams, which it markets under its brands; LiquiBand®, LiquiBand® Fix 8™, RESORBA® and ActivHeal® as well as supplying under white label.
AMS's products, manufactured out of two sites in the
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE